CyberLiver Limited · Carbon Reduction Plan

Care that reaches
people where they are.

CyberLiver builds regulated remote monitoring for liver disease. Patients are managed continuously at home rather than episodically in hospital — which keeps people out of acute beds, releases NHS capacity, and removes journeys that would otherwise be made. This is our Carbon Reduction Plan, and our commitment to Net Zero by 2035.

Net Zero by 2035
25.2 tCO₂e reporting year
PPN 06/21 compliant
Scroll
Our commitment

Net Zero by 2035,
fifteen years early.

CyberLiver Limited is committed to achieving Net Zero emissions by 2035 — a minimum 90% absolute reduction, without relying on offsetting, tree planting or carbon credits to meet the target. That is fifteen years ahead of the 2050 requirement, and ahead of the NHS targets of 2040 and 2045. Our footprint is small and concentrated, so an earlier date is both achievable and appropriate.

25.2 t 2026 12.6 t 2030 2.5 t 2035
2030
50% absolute reduction — 12.6 tCO₂e
2035
Net Zero — 90% absolute reduction, 2.5 tCO₂e residual
2040
NHS Scope 1 and 2 target — we arrive five years earlier
2050
The latest date PPN 06/21 permits. We are not using it
Reporting year

Where our carbon comes from

Reporting year 1 June 2025 – 31 May 2026. Baseline year 1 April 2023 – 31 March 2024. Emissions in tonnes of carbon dioxide equivalent, calculated using UK Government GHG Conversion Factors for Company Reporting.

0tCO₂e
Scope 1 — stated nil return
0.33tCO₂e
Scope 2 — purchased electricity
24.90tCO₂e
Scope 3 — included sources
25.23tCO₂e
Total emissions
25.2
tCO₂e
Business air travel85.5%
Freight — inbound and outbound7.4%
Everything else we do7.1%

Two sources account for 93% of our footprint. Both have a clear route to reduction — a travel policy, and a shift from air to sea freight.

Air travel (business)
21.57
Upstream freight
1.86
Hotel stays
0.79
Rail travel
0.34
Office electricity
0.33
Cloud infrastructure
0.30
Local transport
0.03
Downstream parcels
0.01
Commuting
0.01
Waste
0.00
0

per cent of our footprint is long-haul business flights. A further 7% is freight — and within that, air-freighted breathalysers produce 86% of our shipping emissions while making up just 30% of the weight. Two facts, one reduction plan.

Freight and distribution

The physical side

We are a software company, but our service includes physical health kits. Those components are imported, and devices are posted out. Both are measured and reported.

1.60

Air freight — breathalysers

25 cartons a year flown from China. Just 30% of our shipping weight, but 86% of our shipping carbon. Moving this to sea is under active review and would cut roughly 6% from our total footprint.

0.22

Sea freight — devices

60 cartons a year: 250 weighing scales, 250 blood pressure monitors, 250 thermometers and 300 sling kit bags, shipped from Shenzhen. Longer journey, a fraction of the carbon.

0.01

Downstream — to patients and sites

Breathalysers posted via Royal Mail in reused and recycled packaging. Kit bags are hand-delivered during site visits we are already making, so they add no journey at all.

0

Scope 1 — direct emissions

We own no company vehicles, hold no vehicle fleet, and operate no boilers, generators or on-site fuel combustion of any kind. This is our one nil return, and it is stated rather than left blank.

Environmental management

What we're doing about it

These measures are in effect now and will be applied in the performance of any contract we deliver.

Travel is the target

Because business flights are 85% of our footprint, our reduction plan is first a travel policy. Business need must be evidenced before air travel is approved, and rail is mandated over air for domestic journeys.

Remote-first by design

We hold two desks in a serviced office in Manchester and rarely use them. One colleague walks to the office; another cycles or takes the tram. Our combined annual commuting footprint is six kilogrammes of CO₂e.

Efficient cloud, UK region

Our entire platform runs in AWS Europe (London) on carbon-free energy purchases. Third-party assured reporting puts our annual cloud footprint at 0.30 tCO₂e — under 1% of the total.

Care delivered remotely

Our clinicians monitor and manage patients from a distance, so routine review does not require anyone to travel. The same model applies to how we deliver contracts: implementation, training and account management are remote by default.

ISO 14001 commenced

We have formally begun certification to ISO 14001, which will formalise environmental objectives, monitoring and continual improvement across the organisation.

Freight mode shift

Air-freighted breathalysers are our second-largest single source. Moving them to sea freight, as our other devices already are, is under active review and would cut about 6% of our total footprint.

Wider system impact

Remote monitoring, and the journeys it removes

Continuous monitoring at home replaces a reactive pathway built on crisis admission. Patients are seen sooner, deteriorate less often, and travel less. Hospital care carries a substantial carbon cost, so every avoided admission carries an avoided-carbon benefit for the wider health system — alongside the clinical benefit that is the point of the work.

Reported separately, and deliberately so. The figures below are modelled avoided emissions in third-party organisations. Under PPN 06/21 they do not form part of CyberLiver's own emissions accounting, are not netted against our reported footprint, and play no role in our Net Zero calculation. They are published here because they matter, not because they count.
AlcoChange
Alcohol use disorder and alcohol-related liver disease · UKCA Class IIa
Readmission rate, compliant users vs baseline
4.5×
Readmissions avoided per 100 patients / year
15.7
Acute bed days released
47
Modelled NHS carbon avoided
4.7 t
Mehta et al., JHEP Reports 2024. Baseline 30-day readmission for alcohol withdrawal 20.2% (Phillips et al., 2025). Currently under evaluation in an NIHR-funded randomised controlled trial across 26 NHS hospitals.
CirrhoCare
Decompensated cirrhosis · UKCA Class IIa
Reduction in readmissions vs matched controls
38%
Readmissions avoided per 100 patients / year
13.3
Acute bed days released
93
Modelled NHS carbon avoided
9.3 t
Peer-reviewed pilot published in the Journal of Hepatology, 20 patients versus 20 matched controls. Currently under evaluation in an NIHR-funded randomised controlled trial across 14 NHS hospitals.
Method. Bed days avoided are derived from published readmission outcomes applied to typical lengths of stay. Carbon per acute bed day is estimated at 0.1 tCO₂e, consistent with Greener NHS reporting. Routine outpatient appointments displaced by continuous remote monitoring are estimated separately at approximately 200 per 200 patients per year. These are modelled indicative figures, not measured emissions, and will be validated against real-world deployment data.
Emissions data

Baseline and reporting year

Our baseline is FY2023–24, the first year in which we measured emissions. Our financial year ends on 31 May; this plan is reviewed and updated within six months of that date.

EmissionsBaseline FY2023–24Reporting FY2025–26
Scope 10.000.00
Scope 20.330.33
Scope 3 (included sources)2.7824.90
Total emissions (tCO₂e)3.1125.23

The increase between baseline and reporting year reflects a return to international business travel and a substantially expanded measurement boundary, not a deterioration in operating practice. The baseline captured a narrower set of Scope 3 categories and did not include freight, accommodation, cloud infrastructure or radiative forcing. Air travel is reported on a business-purpose basis; directors\u2019 personal travel is excluded. Air emissions include radiative forcing, the more conservative basis.

Governance

Approval and accountability

Approved by
Ravan Boddu
Chief Operating Officer, on behalf of the board
Net Zero champion
Anu Balaji
Accountable for delivery of this plan
Review cycle
Annual
Within six months of financial year end, 31 May
Published
12 July 2026
cyberliver.com/net-zero.html